cbdMD (YCBD) Convertible Debt (2024)

cbdMD (YCBD) posted Convertible Debt of $362021.0 for Q4 2024, down 69.09% sequentially from $1.2 million in Q3 2024.

cbdMD (YCBD) Convertible Debt (2024) Analysis & Trends

cbdMD has reported Convertible Debt for 1 years, with the latest figure at $362021.0 in Q4 2024.

Quarterly Convertible Debt changed N/A year-over-year to $362021.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $362021.0 (changed N/A YoY) and the FY2024 annual result came in at $1.2 million, changed N/A from the prior year.
Convertible Debt fell to $362021.0 in Q4 2024 per YCBD's latest filing, from $1.2 million in the prior quarter.
Over five years, Convertible Debt peaked at $2.7 million in Q1 2024 and troughed at $362021.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	44.51 Bn	43.55 Bn	-
2	Teva Pharmaceutical Industries	43.52 Bn	39.86 Bn	2.15 Bn
3	Zoetis	32.43 Bn	30.75 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn
5	United Therapeutics	21.87 Bn	19.21 Bn	683.80 Mn
6	Viatris	18.98 Bn	18.09 Bn	1.46 Bn
7	Neurocrine Biosciences	15.43 Bn	15.04 Bn	935.80 Mn
8	Elanco Animal Health	12.02 Bn	11.49 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.14 Bn	9.98 Bn	-
10	cbdMD	5.41 Mn	3.29 Mn	3.04 Mn

Download Data